[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-342464-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-342464-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","clinical-and-immunological-relevance-of-slamf6-expression-in-the-tumor-microenvironment-of-breast-cancer-and-melanoma","Clinical and immunological relevance of SLAMF6 expression in the tumor microenvironment of breast cancer and melanoma","","Compelling evidence links tumor microenvironment T-cell frequency to prognosis and immunotherapy response, yet tumor-infiltrating T cells show major heterogeneity and their genomic and transcriptomic determinants are not fully defined. SLAMF6 is reported on progenitor-exhausted T cells with proliferative and self-renewal capacity. Using public databases, the study tests whether SLAMF6 expression predicts clinical outcomes across immunologically distinct tumor types and characterizes associated effector programs.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/clinical-and-immunological-relevance-of-slamf6-expression-in-the-tumor-microenvironment-of-breast-cancer-and-melanoma/342464/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/clinical-and-immunological-relevance-of-slamf6-expression-in-the-tumor-microenvironment-of-breast-cancer-and-melanoma/342464.png","ImageObject",300,407,{"name":42,"@type":43},"Himbo","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-24","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why is CD8+ T-cell quality important for prognosis and immunotherapy response?","Question",{"text":63,"@type":64},"The text emphasizes that not only CD8+ T-cell quantity but also functional quality predicts outcomes. PD-1 marks exhaustion, but PD-1+ CD8+ subsets show distinct predictive value due to heterogeneity.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What are progenitor-exhausted versus terminally-exhausted T cells?",{"text":68,"@type":64},"Progenitor-exhausted T cells express TCF1 (encoded by TCF7) and show intermediate PD-1, along with stem-like capacity. Terminally-exhausted T cells lack TCF1 and have high PD-1 expression.",{"name":70,"@type":61,"acceptedAnswer":71},"What does high SLAMF6 expression indicate in breast cancer and melanoma?",{"text":72,"@type":64},"The study reports that high SLAMF6 expression is associated with better prognosis and with effector-related gene signatures. Single-cell profiling further shows SLAMF6 overlaps CD8 T cells with a TCF7-linked effector profile, resembling progenitor-exhausted T cells.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},342464,1790330680,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":123,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},687197100911,"https://ap-avatar.wpscdn.com/avatar/a000239b6f1da00475?x-image-process=image/resize,m_fixed,w_180,h_180&k=1785132997149421697","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nClinical and immunological relevance of SLAMF6 expression in the tumor microenvironment of breast cancer and melanoma  \nTakaaki Oba1,4, Mark D. Long2,4, Ken‑ichi Ito1 & Fumito Ito 3*  \nCompelling evidence shows that the frequency ofT cells in the tumor microenvironment correlates with prognosis as well as response to immunotherapy. However, considerable heterogeneity exists within tumor‑infiltrating T cells, and significance of their genomic and transcriptomic landscape on clinical outcomes remains to be elucidated. Signaling lymphocyte activation molecule 6 (SLAMF6) is expressed on intra‑tumoral progenitor‑exhausted T cells, which exhibit the capacity to proliferate, self‑renew and produce terminally‑exhausted T cells in pre‑clinical models and patients. Here, we investigated the impact of SLAMF6 expression on prognosis in two immunologically different tumor types using publicly available databases. Our findings demonstrate that high SLAMF6 expression is associated with better prognosis, expression of TCF7 (encoding T‑cell factor 1), and increased gene signatures associated with conventional type 1 dendritic cells and effector function ofT cells in melanoma and breast cancer. Single‑cell profiling of breast cancer tumor microenvironment reveals SLAMF6 expression overlaps CD8 T cells with aT‑effector signature, which includes subsets expressing TCF7, memory and effector‑related genes, analogous to progenitor‑exhausted T cells. These findings illustrate the significance of SLAMF6 in the tumor as a marker for better effector responses, and provide insights into the predictive and prognostic determinants for cancer patients.  \nType, density and location of immune cell populations play a critical role in prognosis of various solid malignancies1. Particularly, high CD8+ T-cell density is one of the most commonly recognized predictive factors of prognosis as well as response to anti-cancer therapy such as chemotherapy2 and immune checkpoint inhibitor (ICI) therapy3. As ICI therapy becomes the standard-of-care treatment for various cancers; however, we have begun to understand that not only the quantity but also the quality of CD8+ tumor-infiltrating lymphocytes (TILs) is critical predictive and prognostic determents. Indeed, whereas PD-1 expression is the hallmark of‘exhaustion’, a state of dysfunction such as decreased proliferative capacity and effector function4, studies have revealed a remarkable degree of heterogeneity with distinct predictive value amongst PD-1+ CD8+ TILs5,6. Of these, two phenotypically and functionally distinct subsets of exhausted T cells have been identified in pre-clinical and human tumors: ‘progenitor-exhausted’ T cells and ‘terminally-exhausted’ T cells. It has been demonstrated that progenitor-exhausted T cells exhibit stem cell-like properties with the capacity to proliferate, self-renew, and produce terminally-exhausted T cells during ICI treatment7. Accordingly, the presence of progenitor-exhausted T cells, but not terminally-exhausted T cells, in the tumor microenvironment (TME) is essential to the favorable response to ICIs7–10.  \nProgenitor-exhausted T cells are characterized by the expression ofT-cell factor 1 (TCF1, encoded by TCF7) and an intermediate level of PD-1 expression, whereas terminally-exhausted T cells do not express TCF1 but harbor high expression of PD-110. TCF1 was found to be expressed by progenitor-exhausted T cells; however, it is also expressed in naïve T cells11, 12. Hence, it would be difficult to distinguish progenitor-exhausted T cells and other subsets ofT cells only with the use of expression level ofTCF1 and PD-1 .  \nSignaling lymphocyte activation molecule 6 (SLAMF6, encoded by Slamf6 in mice, SLAMF6 in humans) is a homophilic receptor belonging to the superfamily immunoglobulin (Ig) domain-containing molecules, expressed  \n1Division of Breast and Endocrine Surgery, Department of Surgery, ","cbCaipMAiqIsMu78","https://ap.wps.com/l/cbCaipMAiqIsMu78","pdf",7407750,"English","# Introduction\n## Tumor-infiltrating T cell heterogeneity and exhaustion states\n## SLAMF6 as a marker for progenitor-exhausted T cells\n# Hypothesis and study aim\n## Linking SLAMF6 expression to immune activity and survival","[{\"question\":\"Why is CD8+ T-cell quality important for prognosis and immunotherapy response?\",\"answer\":\"The text emphasizes that not only CD8+ T-cell quantity but also functional quality predicts outcomes. PD-1 marks exhaustion, but PD-1+ CD8+ subsets show distinct predictive value due to heterogeneity.\"},{\"question\":\"What are progenitor-exhausted versus terminally-exhausted T cells?\",\"answer\":\"Progenitor-exhausted T cells express TCF1 (encoded by TCF7) and show intermediate PD-1, along with stem-like capacity. Terminally-exhausted T cells lack TCF1 and have high PD-1 expression.\"},{\"question\":\"What does high SLAMF6 expression indicate in breast cancer and melanoma?\",\"answer\":\"The study reports that high SLAMF6 expression is associated with better prognosis and with effector-related gene signatures. Single-cell profiling further shows SLAMF6 overlaps CD8 T cells with a TCF7-linked effector profile, resembling progenitor-exhausted T cells.\"}]","Clinical and immunological relevance of SLAMF6 expression in the tumor microenvironment of breast cancer and melanoma | PDF",1790046695,25,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f236792281f30529b74172449c9fbf4d.webp",983,1291,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2a59cd96bab25e668a28c41aa05219c8.webp",982,1290,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9c05ced264f1bb0531cc32a5b9ad1a5c.webp",981,1289,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e0355a6d5eaaec55e654c4d28a0d5e2a.webp",980,1287]